loadpatents
Patent applications and USPTO patent grants for Schneider; Joel.The latest application filed is for "combination therapy for treating muscular dystrophy".
Patent | Date |
---|---|
Combination Therapy For Treating Muscular Dystrophy App 20220031865 - Ramu; Senthil ;   et al. | 2022-02-03 |
Peptide Hydrogels For Delivery Of Immunosuppressive Drugs And Uses Thereof App 20220016250 - SCHNEIDER; Joel P. ;   et al. | 2022-01-20 |
Peptide Hydrogels And Use Thereof App 20210079042 - Schneider; Joel ;   et al. | 2021-03-18 |
Nanoparticle-hydrogel Composite For Nucleic Acid Molecule Delivery App 20200360296 - Schneider; Joel ;   et al. | 2020-11-19 |
Hydrogels and use thereof in anastomosis procedures Grant 10,086,108 - Schneider , et al. October 2, 2 | 2018-10-02 |
Hydrogels And Use Thereof In Anastomosis Procedures App 20180000983 - Schneider; Joel ;   et al. | 2018-01-04 |
NCAGE Code | 47FJ1 | SCHNEIDER JOEL |
CAGE Code | 47FJ1 | SCHNEIDER, JOEL |
DUNS | 610459294 | SCHNEIDER, JOEL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.